This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects (SHIELD)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2009 by Denver Infectious Disease Consultants, PLLC.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Denver Infectious Disease Consultants, PLLC
ClinicalTrials.gov Identifier:
NCT00740064
First received: August 20, 2008
Last updated: January 27, 2009
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2009
  Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)